Biotech

Shares of Century Therapeutics Inc (NASDAQ:IPSC) zoomed by 20.74% to $1.63 per share on Wednesday, which is the highest price move in nearly a month since Oct. 1. The shares also rose the most in over 11 months since Dec. 6, 2023, in a single day. Also read: Trump’s Tariff Threat To Canada...

Shares of Caballeta Bio Inc (NASDAQ:CABA) rose by 24.38% to $3.01 apiece on Wednesday and advanced by 4.65% to $3.15 per share in after-hours trading, following an update on their Systemic Sclerosis drug trial. Also read: Trump’s Tariff Threat To Canada May Disrupt Oil Markets, Inflate...

Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention. Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With...

Evaxion Biotech A/S (NASDAQ:EVAX) inked an option and licensing deal with Merck & Co., Inc (NYSE:MRK) for two preclinical vaccine candidates. Evaxion also granted Merck an option to license preclinical vaccine candidates EVX-B2 and EVX-B3. EVX-B2 is a protein-based candidate for Gonorrhea, and...

At the Benzinga Healthcare & Biotech Breakthroughs virtual event Thursday, Brian Firth, CEO of Gemina Labs, spoke about the company’s agreement with a major global diagnostics firm, marking a notable step forward for the Canadian-based company. This deal will enhance the performance of...

On Thursday at 11 a.m. EST, Benzinga will host a Healthcare & Biotech Breakthroughs virtual conference. This online event will bring together industry leaders to discuss recent advancements in healthcare and biotechnology that are transforming patient care and creating new investment avenues....

The Structure Therapeutics (NASDAQ:GPCR) stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a significant upside potential. What Happened: JPMorgan has initiated coverage of Structure Therapeutics, a biotech company, with an “Overweight...

U.S. intelligence officials have informed senators that WuXi AppTec Co Ltd (OTC:WXIBF), a Chinese pharmaceutical company, allegedly transferred U.S. intellectual property to Beijing without authorization. This news comes amid concerns that certain Chinese biotech firms are providing technology or...

On Monday, U.S. indices ended the trading day in the green with the Nasdaq gaining 2.2% to 14,843.77. The S&P 500 rose 1.14% to 4,763.54 while the Dow Jones index appreciated nearly 0.6% to 37,683.01. These are the top stocks that gained the attention of retail traders and investors throughout...

The biotech industry has been in the limelight since the COVID-19 pandemic, with public and private sectors pouring in funds to bolster innovation and the development of relevant drugs.  Approximately 63% of public biotech firms reported revenue growth in 2021. Emerging biotech companies,...

Elon Musk is facing another round of allegations of securities fraud, and this time, it comes from a medical ethics group questioning Musk's statement on the death of monkeys at his biotech startup Neuralink. What Happened: Even as Musk claimed that no monkeys died due to Neuralink implants, a new...

Swedish biopharma Calliditas Therapeutics AB (NASDAQ:CALT) is making significant strides in addressing rare kidney diseases. In a recent interview with Benzinga, the company’s CEO, Renee Aguiar-Lucander, provided valuable insights on various aspects of its work. Tarpeyo – A Unique...

Rexis Biotech is dedicated to enhancing the health and well-being of people by manufacturing and distributing high-quality, delicious consumables nationwide. Many find themselves consuming way too much caffeine when the caffeine intake isn’t the issue. Rexis Biotech is looking to solve this....

Shareholders of Johnson & Johnson (NYSE:JNJ) will soon have the opportunity to exchange their shares for those of Kenvue Inc. (NYSE:KVUE), the consumer health company that spun off from J&J two months ago, CNBC reports. What Happened: J&J, which owns nearly 90% of Kenvue shares, plans...

In a recent report, Bank of America identified the “Disruptive Dozen” emerging technologies that have the most potential to disrupt and revolutionize the healthcare sector over the next years. New therapy for ALS (amyotrophic lateral sclerosis) and a blood test for Alzheimer’s...